Navigation Links
Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium
Date:2/11/2008

MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, announced today that the Urgent(R) PC Neuromodulation System, its proprietary, minimally invasive nerve stimulation device, designed for office-based treatment of overactive bladder (OAB) symptoms, will be featured in three presentations at the Society of Urologic Nurses and Associates (SUNA) Annual Symposium. SUNA will be held at the Marriott Waterside Hotel and Marina in Tampa, Florida from Thursday, February 28, through Sunday, March 2. These retrospective and observational studies examined the use of Urgent(R) PC Neuromodulation System to deliver the percutaneous tibial nerve stimulation (PTNS) for the treatment of OAB symptoms of urinary urgency, urinary frequency, and urge incontinence. The Company will present a summary of these presentations on Monday, March 3 before the market opens. The schedule for the oral presentation and poster-discussion sessions is as follows:

-- Leslie Wooldridge, MSN, RNCS, GNP.F, BCIA-PMBD, Director of the Bladder

Control Clinic, Hackley Health at the Lakes Women's Center, Muskegon,

Michigan, "Percutaneous Tibial Nerve Stimulation: Revival of an Old

Technology for Treatment of Overactive Bladder," Sunday, March 2, at 8

am, oral presentation

-- Vanessa K. Hardy, WHNP, APN, MSN, Nurse Practitioner, Urogynecology,

Vanderbilt University Medical Center, Nashville, Tennessee,

"Percutaneous Tibial Nerve Stimulator: A Viable Option for Urgency,

Frequency, and Urge Incontinence," Friday, February 29 through

Saturday, March 1, poster presentation

-- Lesbia Candelaria, RN, Winter Park Urology Associates, Orlando,

Florida, "Percutaneous Tibial Nerve Stimulation (PTNS) Treatment for

Overactive Bladder (OAB) Patients in a Community Based Urology

Practice," Friday, February 29 through Saturday, March 1, poster

presentation

About the Urgent PC Neuromodulation System

The Urgent PC neuromodulation system is a proprietary, minimally invasive nerve stimulation device designed for office-based treatment of OAB symptoms of urge incontinence, urinary urgency and urinary frequency. Application of neuromodulation therapy targets specific nerve tissue and disrupts the signals that lead to the symptoms of OAB. Uroplasty sells the Urgent PC system in the United States, Canada and countries recognizing the CE mark. Outside of the United States, the Urgent PC is also indicated for the treatment of fecal incontinence.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA- approved non-surgical neurostimulation therapy for the treatment of overactive bladder (OAB) symptoms. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, and Treasurer,

952.426.6140

EVC Group

Julie Huang/Matt Selinger (Investors)

646.443.6963

Steve DiMattia/Chris Gale (Media)

646.201.5445


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pathology Reports Good for Breast Cancer Studies
2. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
3. Policy Studies Inc. (PSI) Awarded Contract to Operate the Commonwealth of Kentuckys New Hire Reporting Program
4. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
5. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
6. Stem cell therapy studies for stroke, cerebral palsy prepare for clinical trials
7. UK Center for Tobacco Control Studies to be based in Nottingham
8. Cell division studies hint at future cancer therapy
9. Freeze-dried tendon implants prove effective in early studies
10. Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies
11. ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... it has been awarded the prestigious Distinguished Emerald Club of the World award, ... by BoardRoom magazine, one of the most respected trade publications serving private clubs. ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... based company that has evolved from humble beginnings to being an internationally recognized leader ... company that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized ...
(Date:2/10/2016)... FLA (PRWEB) , ... February 09, 2016 , ... ... team at Clevens Face and Body Specialists are delighted to welcome a new ... ARNP joins Clevens Face and Body Specialists as a nurse practitioner performing ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... REDWOOD CITY, Calif. , Feb. 9, 2016 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it will release financial results for the fourth quarter ... Monday, February 29, 2016. Company management will host a ... p.m. Eastern Time) on Monday, February 29, 2016. ...
(Date:2/9/2016)... Feb. 9, 2016  Insulet Corporation (NASDAQ: PODD ) ... pump technology with its OmniPod ® ... has been appointed to Insulet,s Board of Directors. With ... eight of whom are independent. --> ... audit and finance experience and a deep knowledge of accounting, ...
(Date:2/9/2016)... 9, 2016 QGEN ... den Abschluss eines Kooperationsvertrags mit 10x Genomics ... in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology und ... Frankfurt Prime Standard: QIA) gab heute den ... die Entwicklung und Förderung umfassender Lösungen in ...
Breaking Medicine Technology: